ATG9A Modulated by MiR-195-5p Can Boost the Malignant Progression of Cervical Cancer Cells
Overview
Authors
Affiliations
Cervical cancer (CC) is a major public health problem, and its molecular mechanism requires further investigation. The goal of this study was to determine the role of miR-195-5p and the autophagy-related protein ATG9A in tumour metastasis, epithelial - mesenchymal transition (EMT), apoptosis, and autophagy of CC cells. Using bioinformatics analysis, we predicted ATG9A as a downstream target gene of miR-195-5p, an integral membrane protein required for autophagosome formation and involved in tumorigenesis. Next, western blotting and Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) showed that upregulation of miR-195-5p decreased protein and mRNA expression of ATG9A, and downregulation of miR-195-5p promoted ATG9A protein and mRNA expression. In addition, detection of the dual luciferase reporter gene further indicated ATG9A is a direct downstream target gene of miR-195-5p. Finally, the effects of miR-195-5p and ATG9A on CC cell proliferation, migration, invasion, EMT, autophagy, and apoptosis were evaluated . Our results showed that upregulation of miR-195-5p not only inhibits proliferation, migration, and the EMT of CC cells, but also induces apoptosis and autophagy. Conversely, downregulation of miR-195-5p increased malignant metastasis and the EMT of CC cells, and inhibited apoptosis as well as autophagy. In addition, miR-195-5p targeted and negatively regulated ATG9A, and rescue experiments suggested that overexpression of ATG9A could partially abolish miR-195-5p-mediated suppression of CC cells. Our findings improve our understanding of the mechanism of action of miR-195-5p in the malignant behaviour of CC. miR-195-5p is likely to be a promising cancer suppressor gene, which provides clinical evidence for targeted therapy of CC.
lncRNA ACVR2B-AS1 modulates thyroid cancer progression by regulating miR-195-5p.
Qin T, Lei C, Xiao H, Yang J, Luo Q, Hu L Discov Oncol. 2025; 16(1):267.
PMID: 40045085 PMC: 11883067. DOI: 10.1007/s12672-025-01993-7.
Sun X, Liu C, Chen W, Chen M, Tian H Cytotechnology. 2025; 77(1):29.
PMID: 39744313 PMC: 11685359. DOI: 10.1007/s10616-024-00686-3.
Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer.
Karunakara S, Eswaran S, Mallya S, Suresh P, Chakrabarty S, Kabekkodu S BMC Res Notes. 2024; 17(1):217.
PMID: 39095857 PMC: 11297691. DOI: 10.1186/s13104-024-06876-8.